Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

United Therapeutic (UTHR)

United Therapeutic (UTHR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,662,790
  • Shares Outstanding, K 43,850
  • Annual Sales, $ 1,628 M
  • Annual Income, $ 589,200 K
  • 60-Month Beta 0.91
  • Price/Sales 2.17
  • Price/Cash Flow 5.63
  • Price/Book 1.38

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 2.31
  • Number of Estimates 4
  • High Estimate 3.13
  • Low Estimate 1.88
  • Prior Year 2.42
  • Growth Rate Est. (year over year) -4.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
78.96 +8.58%
on 09/09/19
85.99 -0.30%
on 09/17/19
+4.36 (+5.36%)
since 08/16/19
3-Month
74.31 +15.37%
on 07/23/19
85.99 -0.30%
on 09/17/19
+7.15 (+9.10%)
since 06/17/19
52-Week
74.31 +15.37%
on 07/23/19
129.59 -33.85%
on 10/03/18
-40.21 (-31.93%)
since 09/17/18

Most Recent Stories

More News
United Therapeut Rises 1.01% on Heavy Volume: Watch For Potential Pullback

United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $81.96 to a high of $84.37. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high...

UTHR : 85.98 (+2.93%)
United Therapeutics' Trevyent NDA for PAH Accepted by FDA

United Therapeutics (UTHR) announces acceptance of Trevyent NDA by the FDA for pulmonary arterial hypertension.

ARNA : 51.91 (-0.80%)
MDT : 109.29 (+0.22%)
MNKD : 1.38 (-1.43%)
UTHR : 85.98 (+2.93%)
Correvio Highlights FDA Acceptance of United Therapeutics' Trevyent New Drug Application

NASDAQ: CORV TSX: CORV

CORV.TO : 3.27 (-5.22%)
UTHR : 85.98 (+2.93%)
CORV : 2.46 (-6.11%)
United Therapeutics Announces FDA Acceptance Of Trevyent New Drug Application For Review

United Therapeutics Corporation (Nasdaq: UTHR) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for Trevyent® (treprostinil) for...

UTHR : 85.98 (+2.93%)
iBio Inks 3D Bioprinting Agreement

iBio, Inc. (NYSE AMERICAN:IBIO) today announced that it has entered into a Master Services Agreement ("MSA") with Lung Biotechnology PBC, a subsidiary of United Therapeutics Corporation (NASDAQ:UTHR),...

IBIO : 0.62 (-1.59%)
UTHR : 85.98 (+2.93%)
CLGN : 4.15 (+2.22%)
Correvio Reports Second Quarter 2019 Financial Results

FDA Accepts New Drug Application for Brinavess(TM); PDUFA Date Set for December 24, 2019

CORV.TO : 3.27 (-5.22%)
UTHR : 85.98 (+2.93%)
CORV : 2.46 (-6.11%)
Zoetis (ZTS) Hits Fresh High: Is There Still Room to Run?

Zoetis (ZTS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

NBIX : 101.69 (+3.98%)
ZTS : 122.78 (+2.62%)
INVVY : 3.1300 (-5.21%)
UTHR : 85.98 (+2.93%)
Arena Pharmaceuticals' (ARNA) Q2 Loss Widens, Revenues Meet

Arena Pharmaceuticals (ARNA) incurs wider-than-expected loss in the second quarter of 2019 while revenues are in line.

GH : 74.51 (-0.63%)
BGNE : 132.93 (+0.70%)
ARNA : 51.91 (-0.80%)
UTHR : 85.98 (+2.93%)
Look for Shares of United Therapeut to Potentially Rebound after Yesterday's 2.25% Sell Off

United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $76.94 to a high of $79.26. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of...

UTHR : 85.98 (+2.93%)
United Therapeut Set to Possibly Rebound After Yesterday's Selloff of 2.25%

United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $76.94 to a high of $79.26. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of...

UTHR : 85.98 (+2.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft.

See More Share

Trade UTHR with:

Business Summary

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability....

See More

Key Turning Points

2nd Resistance Point 86.56
1st Resistance Point 85.04
Last Price 85.98
1st Support Level 80.86
2nd Support Level 78.20

See More

52-Week High 129.59
Fibonacci 61.8% 108.47
Fibonacci 50% 101.95
Fibonacci 38.2% 95.43
Last Price 85.98
52-Week Low 74.31

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar